Multiple important steps have contributed to the advancement of the BriaCell clinical program in 2018 The company has gotten excellent results from its Bria-IMT clinical trials and hopes to begin Bria-OTS testing in 2019 The personalized, off-the-shelf advanced breast cancer treatment will be much more cost-effective to manufacture than alternatives and is expected to produce […]
The Stocks To Buy Now Blog
Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.